| 1 |
28752785 | Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection. | 2018 Feb |
2 |
| 2 |
29484976 | New Life to an Old Treatment: Pegylated Interferon Beta 1a in the Management of Multiple Sclerosis. | 2018 |
1 |
| 3 |
28129467 | Novel pegylated interferon-β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer. | 2017 Apr |
1 |
| 4 |
30050377 | Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a. | 2017 |
1 |
| 5 |
27800024 | An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis. | 2016 Nov |
2 |
| 6 |
25666445 | Peginterferon beta-1a: a review of its use in patients with relapsing-remitting multiple sclerosis. | 2015 Feb |
1 |
| 7 |
26056458 | Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis. | 2015 |
1 |
| 8 |
23962003 | Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b. | 2013 Dec |
8 |
| 9 |
21680782 | A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology. | 2012 Jun |
1 |
| 10 |
21690216 | In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a. | 2011 Sep |
4 |
| 11 |
22156480 | Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy. | 2011 |
1 |
| 12 |
2488591 | Isoelectric focusing of recombinant interferon-beta. | 1989 |
2 |
| 13 |
6678936 | Purification of human fibroblast interferon by extraction in aqueous two-phase systems. | 1983 Feb-Apr |
2 |